The Alzheimer’s Disease and Memory Disorders Center (ADMDC) conducts clinical trials that give participants access to the latest, most comprehensive diagnostic and treatment options available.
There is currently no cure for Alzheimer's disease, but scientists are constantly working to advance research through clinical studies with the help of human volunteers. Without these volunteers, there can be no better treatments, prevention, or cure for Alzheimer's.
Both people with the disease and healthy volunteers are needed for Alzheimer's-related clinical trials. Before joining a clinical trial, an individual must qualify for the study. All clinical trials have guidelines about who can participate. These criteria are based on factors such as age, gender, the type and stage of the disease, previous treatment history, and other medical conditions.
Metformin in Alzheimer's Dementia Prevention (MAP)
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of SAGE-718 in Participants with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer’s Disease
Long-Term Nicotine Treatment of Mild Cognitive Impairment (NIC)
Donanemab in Early Symptomatic Alzheimer’s Disease (TRAILBLAZER-ALZ 2)
Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer’s Disease (MTAE)
The research focus of this laboratory is to characterize the contribution of CNVs to the genetic architecture of AD to develop genetic biomarkers for risk stratification.
For Consultations, Referrals, and Information:
Alzheimer's Disease and Memory Disorders Center
Clinic Locations:
1001 Main Street, Fl 4
Buffalo, NY 14203
716-829-5056
5851 Main Street
Williamsville, NY 14221
716-829-5056